ArrowMark Partners
Investment Details
Investor Type
Private Investment Firm
Asset Class Focus
Fixed Income (Debt and Bonds), Equity, Real Estate
Stage Focus
Growth, Late Stage, Buyout, Turnaround, Distressed
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, China, India, Brazil, France, Italy, Denmark, Switzerland, Spain, Mexico, South Korea, Netherlands, Sweden, Belgium, Norway
Industries Focus
- Financial Services
- Technology
- Healthcare
- Energy
- Consumer Goods
- Real Estate
- Materials
- Telecommunications
- Utilities
- Media
- Retail
- Education
- Transportation
- Consumer Services
- Industrial Goods
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2007
ArrowMark Partners is a privately held, employee-owned investment management firm founded in 2007 and headquartered in Denver, Colorado. The firm focuses on niche and less efficient market segments across public and private credit and equity, leveraged loans, and middle-market commercial real estate finance. Their integrated investment platform allows them to deliver differentiated investing outcomes for clients by leveraging their size, agility, and specialized expertise.
The firm's investment strategies include multi-sector credit, multi-asset, equity, and commercial real estate finance. As of June 30, 2025, ArrowMark Partners manages approximately $22.0 billion in assets on behalf of a broad array of institutional clients and private wealth allocators. Their team comprises experienced professionals with an average of 15 years in the investment industry, enabling them to navigate market cycles effectively and manage complex risk/reward tradeoffs.
ArrowMark Partners has been recognized for its achievements, including receiving the Real Estate Capital USA’s 2023 Small Ticket Lender of the Year award. The firm continues to expand its capabilities and offerings to meet the evolving needs of its clients, maintaining a commitment to delivering superior risk-adjusted returns across multiple investment disciplines.
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Arbor Biotechnologies
- Zenas BioPharma
- Freenome
- SmartLabs
- Beta Bionics
- Checkerspot
- Aktis Oncology
- Dren Bio
- Simcha Therapeutics
- Big Health
- Fyllo
- SkyRyse
- DNA Script
- Sonoma Biotherapeutics
- Frontier Medicines
- Tvardi Therapeutics
- binx health
- Adagio Therapeutics
- Dataminr
- Amunix Pharmaceuticals
Mentioned In
Claim this Investor
Are you an official representative of ArrowMark Partners?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim